...
首页> 外文期刊>Histochemistry and cell biology >A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells.
【24h】

A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells.

机译:过氧化物酶体增殖物激活的受体-γ配体可以调节人肝星状细胞上瘦素受体的表达。

获取原文
获取原文并翻译 | 示例

摘要

Leptin is a peptide known to play a profibrogenic role in hepatic stellate cells (HSCs). Peroxisome-proliferator activated receptor (PPAR)-gamma ligands are suggested to have an anti-fibrogenic effect on HSCs. Since the association of these two factors in HSC activation has not been demonstrated, we hypothesized that PPAR-gamma ligands would suppress leptin-induced HSC activation and regulate leptin receptor expression. Immortalized human HSCs were activated by either leptin or platelet-derived growth factor (PDGF) in one group. In another group, ciglitazone, a PPAR-gamma ligand, was treated before the leptin or PDGF stimulation. Proliferation of human HSCs was achieved by both PDGF and leptin, and this could be suppressed by ciglitazone. PPAR-gamma mRNA expression was diminished in activated HSCs either by PDGF or leptin, and this was reversed by ciglitazone in both cases. Leptin receptor (OB-R) mRNA expression increased in activated HSCs either by PDGF or leptin, and the expression was inhibited by ciglitazone. Another adipogenic transcription factor, sterol regulatory element-binding protein-1c (SREBP-1c) mRNA expression was decreased either by PDGF or leptin. However, this effect was not reversed by ciglitazone pre-treatment. The inhibitory effect of ciglitazone on leptin-induced HSC proliferation was associated with the reversion of extracellular factor-regulated kinases (ERKs) activation. HSCs were OB-R expressing cells, and ciglitazone could regulate the expression of OB-R mRNA.
机译:瘦素是一种已知在肝星状细胞(HSC)中发挥促纤维化作用的肽。建议过氧化物酶体-增殖物激活受体(PPAR)-γ配体对HSC具有抗纤维化作用。由于尚未证明这两个因素在HSC激活中的关联,我们假设PPAR-γ配体会抑制瘦素诱导的HSC激活并调节瘦素受体的表达。在一组中,永生化的人类HSC被瘦素或血小板衍生的生长因子(PDGF)激活。在另一组中,在瘦素或PDGF刺激之前先治疗西格列酮(一种PPAR-γ配体)。 PDGF和瘦素均可实现人HSC的增殖,而西格列酮可抑制这一增殖。 PDGF或瘦素可降低激活的HSC中PPAR-γmRNA的表达,在两种情况下,西格列酮均可逆转PPAR-γmRNA的表达。 PDGF或leptin在激活的HSC中增加了瘦素受体(OB-R)mRNA的表达,而西格列酮抑制了该表达。 PDGF或瘦素降低了另一种成脂转录因子,固醇调节元件结合蛋白1c(SREBP-1c)mRNA的表达。但是,西格列酮预处理不能逆转这种作用。西格列酮对瘦素诱导的HSC增殖的抑制作用与细胞外因子调节激酶(ERKs)激活的逆转有关。 HSCs是OB-R表达细胞,西格列酮可以调节OB-R mRNA的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号